LATEST ALERTS
Shortly after drafting its first proposal on cannabis regulation, the Czech government has banned semi-synthetic cannabinoids HHC, HHC acetate (HHC-O) and tetrahydrocannabiforol (THCP)
Cannabinoids can be found in numerous plants, animals and fungi, and as more are unearthed and their properties tested, our knowledge of potential applications and uses expands
Young US adults are more likely to use cannabis than to vape or smoke cigarettes, says a new Gallup poll, and concerns about cannabis use are not comparable to fears around vaping and smoking
The US Federal Trade Commission and Food and Drug Administration have sent warning letters to six sellers of delta-8 THC edibles whose packaging is very similar to that of popular snacks and sweets for children
US cannabis users are three times more likely to be cigarette smokers than those who don’t use cannabis, but this statistic is an example of the “gateway drug fallacy”
This report provides an overview of the current regulatory framework in place in South Africa for hemp, CBD and other cannabinoids, as well as medical and recreational cannabis
Researchers at the US Food and Drug Administration (FDA) recently published a review on the toxicity of orally-consumed CBD, largely echoing worries outlined in other safety reviews. So how worried should we be?
Kombinat Konopny CEO and founder Maciej Kowalski talks to podcast host Oliver Prescott about the company’s win in Poland’s high court, subsequent changes in the industry and current cannabis food policy in Europe
A new study of the relationship between opioids and cannabis via payments to doctors in US states offers little towards understanding the potential of cannabis as a substitute for opioids
While statistics are vital to understanding our world, they are often misunderstood – and that can be important when it comes to forming opinions and laws on controversial issues such as cannabis
Comments by the chair of the UK Committee on Toxicity (COT) about reactions to CBD have stirred up a hornet’s nest – but the furore suggests a misunderstanding of what he actually said
Kanavape founder Sebastien Beguerie talks with CannIntelligence podcast host Tiziana Cauli about his judicial battle leading to a crucial European Court of Justice ruling which established CBD legal status across Europe
Cannabis companies are looking to get Google certification as part of the tech giant’s update on the use of Google Ads for CBD products in parts of the US
The US Food and Drug Administration (FDA) has issued a final guidance document for the development of medical drugs containing cannabis
CBD company Chanelle McCoy Health has received approval to start a trial which may allow it to sell its CBD sleeping aid as an over-the-counter (OTC) drug in Australian pharmacies
The recreational reputation of synthetic cannabinoids – synthetic cannabinoid receptor agonists (SCRAs) – precedes them, leading to restrictions on use and even research
Despite what its authors claim, a new and widely reported study fails to establish that the analgesic properties of cannabis can be largely attributable to the placebo effect
New research suggests that the effect of cannabis on dopamine may help to treat certain symptoms of bipolar disorder, with a reduced tendency to engage in risky behaviours and some improvement in cognitive ability
Legal hurdles impeding recreational cannabis legalisation in Mexico are expected to continue through 2024, industry members told CannIntelligence during the CannaMexico conference last month
The UK Advertising Standards Authority (ASA) has taken action on CBD product marketing, targeting a series of advertorials produced by Consumer Logic Research specifically promoting two brands
The UK is lagging behind other major markets in the world on research into the benefits of medicinal cannabis, according to a scientist specialising in the area
A major new study into the impact of cannabis on the brain has attracted controversy and accusations of bias from within the industry before it even begins
Smoking cigarettes is going out of fashion, but having smoked cannabis is becoming much more common in the US, according to recent research conducted by analytics and polling firm Gallup
Reducing opioid dependence is a primary goal of medical cannabis programmes, but there remains a need for rigorous science when making decisions about the interaction between cannabis and opioid use for pain
A recent study has shown that CBD can reduce the psychoactive effects of THC – a discovery which could advance the clinical application of medical cannabis
As the US midterm elections approach, questions are being raised about the actions the Biden administration has taken to meet campaign promises regarding drug reform
The Biden Administration recently released a memorandum requiring research receiving federal funds to be made available to the public without charge. But what effect will this have on cannabis research?
A new conceptual inhaler designed around the idea of controlled microdosing could eventually lead to a product capable of administering precise amounts of active ingredients such as CBD, nicotine or even psychedelics
US law enforcement is working alongside toxicologists and cannabis breathalyser developer Cannabix Technologies to test and compare various methods of detecting cannabis intoxication
The US Drug Enforcement Administration (DEA) has issued a pre-solicitation notice to approved medical cannabis producers, the next step in securing new suppliers of cannabis for research purposes after a monopoly was ended
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.
"*" indicates required fields
Get 7 days of access to industry updates through our news analysis and regulatory alerts
"*" indicates required fields
Notifications
